Startup
Dualyx
Startup · Ghent, Belgium
VIB-linked biotech developing Treg-based immune modulators for hard-to-treat autoimmune diseases. Lead program DT-001 is a TNFR2 antibody agonist in IND-enabling studies. Founded 2020; raised EUR 40M Series A in 2023.
Connection map
Affiliation
Drag nodes to rearrange · scroll or pinch to zoom · click a node to open it